Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
UBS
AstraZeneca
Federal Trade Commission
Express Scripts
Johnson and Johnson
Colorcon
Accenture
Fuji

Generated: January 18, 2018

DrugPatentWatch Database Preview

Natco Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for NATCO PHARMA, and what generic and branded alternatives to NATCO PHARMA drugs are available?

NATCO PHARMA has nineteen approved drugs.

There is one tentative approval on NATCO PHARMA drugs.

Summary for Natco Pharma
US Patents:0
Tradenames:16
Ingredients:16
NDAs:19

Drugs and US Patents for Natco Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 200482-001 Dec 31, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077141-002 Apr 10, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd CARISOPRODOL carisoprodol TABLET;ORAL 090988-001 Oct 28, 2014 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 091621-001 Jan 21, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203478-002 Jul 1, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 202768-001 Nov 28, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd ALPRAZOLAM alprazolam TABLET;ORAL 200739-001 Apr 15, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 203306-001 Jan 13, 2016 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd ANASTROZOLE anastrozole TABLET;ORAL 079220-001 Jun 28, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Natco Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 202768-004 Sep 28, 2017 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Johnson and Johnson
Daiichi Sankyo
Novartis
Citi
Express Scripts
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot